Close

Tag: Coronavirus information (COVID-19)

Pharma-manufacturing network likely to remain unscathed despite COVID-19

Most of the pharmaceutical companies do not plan to change their manufacturing network despite the possibility that COVID-19 pandemic may disrupt supply channels. GlobalData has...

Akston Biosciences and LakePharma Enter Covid-19 Partnership

Akston Biosciences, which develops new classes of biologic therapeutics, and LakePharma, a U.S.-based CRDMO serving the biotechnology community with development and production services, have...

INOVIO, Advaccine Enter Exclusive COVID-19 DNA Vax Pact

INOVIO, a biotechnology company focused on precisely designed DNA medicines to treat and prevent infectious diseases and cancer, and Advaccine Biopharmaceuticals Suzhou, an emerging...

Bharat Biotech vaccine approved in clinical trial mode, consent of participants has to be taken: ICMR

Balram Bhargava, chief of Indian Council of Medical Research (ICMR), said on Tuesday that Bharat Biotech’s Covid-19 vaccine has been cleared in the clinical...

Chemo Drug Potentially More Potent than Remdesivir Against Coronavirus

Researchers with Shenzhen Institutes of Advanced Technology in China used a variety of computational techniques to simulate drug-virus interactions. They then screened 1,906 existing...

Covid 19: An opportunity in disguise for E-Pharmacies in India

Apex industry body, Federation of Indian Chambers of Commerce & Industry (FICCI) has forecasted that the e-pharmacies in India will grow rapidly and cater...

Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804

Incyte and Cellenkos, Inc., a privately held, clinical stage biotech company, announced a development collaboration to investigate the combination of ruxolitinib (Jakafi®) and CK0804,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read